Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06413147
Other study ID # yinchunlin_PFO safety
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date May 30, 2024
Est. completion date May 30, 2029

Study information

Verified date May 2024
Source Xuanwu Hospital, Beijing
Contact Chunlin Yin
Phone 13552566227
Email yinclmail@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

We aimed to explore: (1)long-term complications of PFO closure; (2) antiplate or anticoagulation use after PFO closure.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date May 30, 2029
Est. primary completion date May 30, 2029
Accepts healthy volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - All patients who underwent PFO closure Exclusion Criteria: - Unable to complete or adhere to the study

Study Design


Related Conditions & MeSH terms


Intervention

Device:
PFO closure
Surgery of PFO closure

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Xuanwu Hospital, Beijing

Outcome

Type Measure Description Time frame Safety issue
Primary ischemic stroke, Hemorrhagic stroke or transient ischemic attack 1 month, 6 months, 1 year, 3 years, 5 years
Secondary atrial fibrillation 1 month, 6 months, 1 year, 3 years, 5 years
Secondary Hemorrhage related to the use of antithrombotic drugs 1 month, 6 months, 1 year, 3 years, 5 years
Secondary residual leaks 1 month, 6 months, 1 year, 3 years, 5 years
Secondary death 1 month, 6 months, 1 year, 3 years, 5 years
Secondary open-heart surgery 1 month, 6 months, 1 year, 3 years, 5 years
Secondary Other severe events related to PFO closure 1 month, 6 months, 1 year, 3 years, 5 years
See also
  Status Clinical Trial Phase
Completed NCT06192173 - Patent Foramen Ovale Closure in Migraine
Recruiting NCT04610463 - Evaluation of the Severity of Right to Left Shunt in PFO Patients After Systemic Embolism N/A
Completed NCT02882815 - Post Market Clinical Follow-up Study of IrisFITTM PFO (Patent Foramen Ovale) Occluder N/A
Completed NCT04604015 - RoBotic TCD Ultrasound BubbLe Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt N/A
Active, not recruiting NCT04950192 - Philips Intracardiac Echocardiography (ICE) Clinical Registry
Not yet recruiting NCT04549272 - Assessment of Early Vascular Damage With Advanced Neuroimaging in Patient With Patent Foramen Ovale
Completed NCT02621528 - Lifetech CeraFlex™ Post-Market Surveillance Study N/A
Terminated NCT01018355 - The Effect of Device Closure of Patent Foramen Ovale in Elderly Patients With Crytogenic Stoke/TCI N/A
Completed NCT00831259 - Risk of Stroke in Pulmonary Embolism With a Patent Foramen Ovale (PFO) N/A
Not yet recruiting NCT05360771 - Study on the Safety and Effectiveness of the SnowyTM PFO Closure System N/A
Recruiting NCT05546320 - Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale Phase 4
Recruiting NCT05561660 - COMParison of the EffecT of dEvice Closure in Alleviating Migraine With PFO (COMPETE-2) Phase 4
Completed NCT03904277 - Does Patent Foramen Ovale Size Matter in Men and Women
Recruiting NCT06120270 - CeraFlex PFO Closure System PMCF Study
Terminated NCT01773252 - Right to Left Cardiac Shunt Detection Phase 3
Completed NCT01216423 - Pulmonary Embolism and Stroke in Patient With Patent Foramen Ovale N/A
Completed NCT03377465 - Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis N/A
Active, not recruiting NCT04738071 - International Multicenter Patent foRamen OVale & strokE (IMPROVE) Registry
Not yet recruiting NCT06344494 - Cardiac Interventional ICE Imaging Trial N/A
Withdrawn NCT02378623 - Patients With Patent Foramen Ovale and Endocardial Device Leads on Apixaban for Prevention of Paradoxical Emboli Phase 2